Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes-EV-based Therapeutics Summit

Behzad Mahdavi's Biography

Behzad Mahdavi, Vice President of Strategic Innovation & Alliances, Lonza

Behzad Mahdavi is serving as Vice President of Strategic Innovation & Alliances at Lonza, one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets, as a Chairman of the Board of Exosomics, an innovator leader in the field of Exosome-Based Liquid Biopsy and as a member of Investment and Advisory committee for C3E Venture Capital Fund, one of the most active private fund in Canada. He began in his current position at Lonza in 2010 after three years working as Head of Lonza Canada.

Prior to joining Lonza, he was CEO of SAM Electron Technologies, a venture capital-backed company in the Life Sciences field, which was acquired in 2007 by a multinational company. During his entire career, Behzad worked for several private organizations, governmental companies and venture capital firms in different capacities as senior executive, advisor, CEO and board member. In these roles, he was involved in leading, managing and advising technological start-ups/companies in fund raising, strategic business development, efficient innovation management and commercialization/spinoff to create new profitable growth axis.

He earned his MBA from the University of Quebec in Montreal, Canada, his Ph.D. in Chemistry from University of Sherbrooke, Canada, his MS in Industrial Chemicals & Environment from the University of Rennes, France and his BSc in Chemical Engineering from ENSCR, France.

Behzad Mahdavi Image

Exosome, The Next Small Thing: A Winning Strategy to Lead its Manufacturing and Characterization

Friday, 1 November 2019 at 13:30

Add to Calendar ▼2019-11-01 13:30:002019-11-01 14:30:00Europe/LondonExosome, The Next Small Thing: A Winning Strategy to Lead its Manufacturing and CharacterizationExosomes-EV-based Therapeutics Summit in Rotterdam, The NetherlandsRotterdam, The

  • Importance of Exosomes in Precision Medicine and Targeted Delivery
  • How expertise and assets in cell manufacturing are essential for Exosome manufacturing  
  • Leverage the exosome-based liquid biopsy, characterization and profiling in therapeutic development manufacturing
  • Cell Therapy Manufacturing + Exosomes Based Liquid Biopsy = A winning combination to lead Exosomes Manufacturing

Add to Calendar ▼2019-11-01 00:00:002019-11-01 00:00:00Europe/LondonExosomes-EV-based Therapeutics SummitExosomes-EV-based Therapeutics Summit in Rotterdam, The NetherlandsRotterdam, The